Bavarian Nordic at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Bavarian Nordic brings 3 presentations to IDWeek 2026 in Washington, and exhibits at Booth 1706. Its program centres on vaccines against chikungunya and on how the MVA-BN vaccine performs in children compared with adults. One study finds that a single dose of its chikungunya vaccine produces antibodies that neutralize different virus lineages and related alphaviruses.

OrganizationIDWeek 2026 Attendance
Bavarian Nordic
Durham, NC
Large pharma
Danish vaccine maker whose products include the Jynneos mpox and smallpox vaccine and a chikungunya virus-like particle vaccine.
Booth
Exhibiting at Booth 1706
Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm
Talk
Sat Oct 24
11:30am–11:42am
Part of Late Breaking Abstracts: Vaccinology
Real-world Use and Safety of a Chikungunya Virus Virus‑like Particle Vaccine
206
Vaccines
Poster
Sat Oct 24
12:15pm–1:30pm
Chikungunya Virus Virus-like Particle Vaccine Elicits Cross-Neutralization Across CHIKV Lineages and Against Other Alphaviruses After Single Dose
Poster Hall B-C · Poster P-1164
I4. New vaccines

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bavarian Nordic

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction